Chlorogenic Acid Composition for Hyperlipidemia Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hyperlipidemia lack a unified diagnostic standard and effective, side-effect-free therapeutic options that can significantly reduce serum total cholesterol and triglyceride levels while increasing high-density lipoprotein levels.
Innovation Solution
A pharmaceutical composition combining chlorogenic acid with vitamins, particularly vitamin C, and trace elements like manganese gluconate, formulated into various administration forms such as injections, tablets, and capsules, which are prepared using specific steps to ensure stability and bioavailability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If statins or other medicaments are used to treat hyperlipidemia, then serum total cholesterol and triglyceride levels are reduced, but side effects occur
Solution Approach 1:
The patent combines multiple natural components (chlorogenic acid, vitamins C and E, zinc, selenium, manganese) into a composite pharmaceutical formulation. This composite approach achieves lipid-lowering effects through synergistic interactions among the components, providing an alternative to conventional statins that cause side effects. The combination formula addresses the contradiction by delivering therapeutic efficacy while avoiding the harmful side effects associated with synthetic medications.
Solution Approach 2:
The patent employs natural, readily available substances (chlorogenic acid from plants, common vitamins and trace elements) that can be obtained through diet or simple extraction. These natural components are replaced in the body and require continuous supplementation, functioning as a sustainable, renewable therapeutic approach that avoids the accumulation of harmful synthetic compounds.
2Reliability
If vitamins and trace elements are supplemented to regulate lipid metabolism, then blood lipid levels may be regulated, but excessive supplementation leads to health problems
Solution Approach 1:
The patent precisely controls the dosage parameters of each component in the formulation. Chlorogenic acid is combined with specific amounts of vitamins (C and E) and trace elements (zinc, selenium, manganese) in optimized ratios. This parameter optimization ensures therapeutic effectiveness for lipid regulation while preventing the toxic effects of excessive supplementation. The formulation transforms the potential harm of over-supplementation into benefit through careful dosage control.
Solution Approach 2:
The patent employs a balanced formulation where multiple components work together in a feedback system. The natural components support each other's functions and regulate each other's effects, preventing any single component from reaching excessive levels that would cause harm. This balanced composition provides automatic regulation to avoid the health problems associated with excessive vitamin or trace element supplementation.
3Reliability
If conventional drug therapy is used forhyperlipidemia, then cholesterol and triglyceride levels are reduced, but unified diagnostic and treatment standards are lacking
Solution Approach 1:
The patent creates a universal pharmaceutical formulation that can be applied across different types of hyperlipidemia cases. The multi-component formula (chlorogenic acid combined with vitamins and trace elements) addresses multiple aspects of lipid metabolism simultaneously, providing a standardized treatment approach that can be universally applied regardless of the specific type or cause of hyperlipidemia, thereby resolving the lack of unified treatment standards.
Data Source
AI summary
A pharmaceutical composition for treating hyperlipidemia and a preparation method therefor are provided. The pharmaceutical composition contains chlorogenic acid, vitamins, pharmaceutically acceptable excipients and optional microelements. The pharmaceutical composition for treating hyperlipidemia reduce can serum total cholesterol and serum triglyceride, and increase the content of high-density lipoproteins.